Status:
NOT_YET_RECRUITING
The Nociception Level (NOL) Index for Pain Assessment in the Adult Intensive Care Unit
Lead Sponsor:
McGill University
Collaborating Sponsors:
Jewish General Hospital
Maisonneuve-Rosemont Hospital
Conditions:
Pain, Acute
Nociceptive Pain
Eligibility:
All Genders
18+ years
Brief Summary
Assessing pain in the adult intensive care unit (ICU) is challenging because many patients are unable to communicate due to mechanical ventilation and sedation. Therefore, it is necessary to have alte...
Detailed Description
Background: Assessing pain in adult intensive care units (ICU) is challenging because self-report is often non-feasible due to patients' critical care conditions, mechanical ventilation and/or sedatio...
Eligibility Criteria
Inclusion
- Admitted to the ICU for more than 24 hours
- French or English speaking
- Able to self-report or not
- Negative on delirium screening and not treated for psychosis (patients able to self- report)
Exclusion
- Lack an available finger to install the NOL's finger probe
- Suffer severe peripheral vascular disease affecting the upper limbs
- Serious and uncontrolled cardiac arrhythmia
- Are in a hypoperfusion state or shock for which they are receiving high doses of Norepinephrine (\>14 mcg/min) or equivalent vasopressors to maintain a SBP \>90mmHg or a MAP \>65mmHg
- Are agitated (RASS scores from +1 to +4)
- Diagnosed with cognitive deficits (e.g., Alzheimer)
- Are positive for C. Difficile
- Are pregnant
Key Trial Info
Start Date :
May 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2026
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT05339737
Start Date
May 1 2022
End Date
March 31 2026
Last Update
April 21 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.